3.7(top 10%)
impact factor
928(top 20%)
papers
15.3K(top 10%)
citations
55(top 10%)
h-index
3.7(top 10%)
extended IF
997
all documents
17.3K
doc citations
84(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Resting‐state network dysfunction in Alzheimer's disease: A systematic review and meta‐analysisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017288
2Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017283
3Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profileAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2016255
4Automatic speech analysis for the assessment of patients with predementia and Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015217
5Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive StudyAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2016209
6Consensus guidelines for lumbar puncture in patients with neurological diseasesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017197
7Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trialsAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015191
8Body mass index in midlife and dementia: Systematic review and meta‐regression analysis of 589,649 men and women followed in longitudinal studiesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017169
9The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directionsAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2018169
10Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: A systematic reviewAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2018162
11Retinal thickness in Alzheimer's disease: A systematic review and meta‐analysisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017152
12A systematic review and meta‐analysis of retinal nerve fiber layer change in dementia, using optical coherence tomographyAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015133
13Cognitive impairment and decline in cognitively normal older adults with high amyloid‐β: A meta‐analysisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017131
14Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individualsAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017129
15Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicityAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2018126
16Retinal microvascular network attenuation in Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015122
17Association between air pollutants and dementia risk in the elderlyAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015116
18Cognitive performance before and after the onset of subjective cognitive decline in old ageAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015110
19Retinal blood flow in mild cognitive impairment and Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015108
20Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015105
21The Quick Dementia Rating System (QDRS): A rapid dementia staging toolAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2015100
22The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta‐analysisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2019100
23Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteersAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201995
24Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201893
25Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrinAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201793
26Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle‐age adults at risk of ADAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201590
27The incidence of mild cognitive impairment: A systematic review and data synthesisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201989
28Tau‐PET uptake: Regional variation in average SUVR and impact of amyloid depositionAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201786
29Tau positron emission tomography imaging in tauopathies: The added hurdle of off‐target bindingAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201886
30Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201986
31Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studiesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201984
32The application of retinal fundus camera imaging in dementia: A systematic reviewAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201783
33Nonvascular retinal imaging markers of preclinical Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201682
34Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201581
35Revolutionizing Alzheimer's disease and clinical trials through biomarkersAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201580
36Cerebral atrophy in mild cognitive impairment: A systematic review with meta‐analysisAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201579
37Repetitive head impact exposure and later‐life plasma total tau in former National Football League playersAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201779
38Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementiaAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201577
39Retinal thickness correlates with parietal cortical atrophy in early‐onset Alzheimer's disease and controlsAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201877
40Plasma amyloid beta levels are associated with cerebral amyloid and tau depositionAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201977
41T‐MoCA: A valid phone screen for cognitive impairment in diverse community samplesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring202174
42Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z‐scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201672
43White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegenerationAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201671
44Change in retinal structural anatomy during the preclinical stage of Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201871
45Complement protein levels in plasma astrocyte‐derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementiaAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201970
46Measuring longitudinal cognition: Individual tests versus compositesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201969
47Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomicsAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201668
48Computer mouse movement patterns: A potential marker of mild cognitive impairmentAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201566
49Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3‐PET studyAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201766
50Developmental lead exposure and lifespan alterations in epigenetic regulators and their correspondence to biomarkers of Alzheimer's diseaseAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201665